NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Genomatica, Inc.

Genomatica, Inc.

Private
San Diego, CaliforniaEnergy & Sustainabilityhttps://www.genomatica.com/

Last Round

Joint Venture

Jun 16, 2022

Total Funding Raised

$324.23M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Genomatica, Inc. is a biotechnology company that develops commercial biobased processes to produce essential chemicals for sustainable everyday products.

Sector

Energy & Sustainability

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing, Circular Economy

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Infrastructure

Keywords

bio-based chemicalssynthetic biologyrenewable chemicalsbiomanufacturingsustainable materialsbio-based nylonmetabolic engineeringstrain designgreen chemistrybio-polybutadienebutylene glycolbiotech platformcircular economydrop-in chemicalsindustrial biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genomatica, Inc. Comps

Public and private peers based on sector, stage, and business model.

Genomatica, Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Genomatica, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Joint VentureJun 16, 2022
Series CJul 27, 2021
VC RoundOct 3, 2018
Series DAug 2, 2012
GrantAug 1, 2011
Series C Extension
Apr 1, 2011

Key People

Founding team and executive leadership

Chris Gann

CEO

Executive Team

John G. Gugel

Chief Executive Officer

Executive Team

Tom McDonald

Chief Financial Officer

Executive Team

Genomatica, Inc. Investors

Notable investors and investment history

Genomatica, Inc. investors
InvestorRounds
Tenere CapitalSeries C
Bright CapitalSeries C Extension
Nicholas Investment PartnersSeries C
Alloy VenturesSeries C, Series B, Series A, Series C Extension, Series D, Series A Extension
DFJ VenturesSeries C, Series D
Mohr Davidow VenturesSeries C, Series B, Series A, Series C Extension, Series D
Irving InvestorsSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors increased 117% MoM, reaching 6.4K.

  • Oct 13, 2025

    Partnered with Sojitz Corporation to commercialize plant-based nylon-6.

Genomatica, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Genomatica, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Genomatica, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range232
Year Founded2000
Last FundingJun 16, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.